Skip to main content
. Author manuscript; available in PMC: 2010 Jan 11.
Published in final edited form as: Genes Immun. 2009 Dec;10(Suppl 1):S54–S59. doi: 10.1038/gene.2009.92

Table 2.

TCF7 SNPs studied

Marker Name Position HW P value founders % Call rate Number of trios MAF Alleles (major:minor)
1 rs30503 133465245 0.36 97.9 1541 12.7% C:G
2 rs30500 133467775 0.03 96.2 1492 18.4% C:T
3 rs30499 133469625 0.08 99.4 1584 23.5% A:G
4 rs244948 133472960 0.16 98.6 1554 13.6% G:A
5 rs5742913 (ss93257904) 133479582 0.72 98.6 1568 11.6% C:A
6 rs244692 133480434 0.16 98.5 1563 8.3% A:G
7 rs151822 133483860 0.08 99.3 1576 23.1% T:C
8 rs152404 133486613 0.13 98.8 1564 14.7% T:C
9 rs152406 133489485 1.00 99.6 1597 5.2% G:A
10 rs249611 133492556 0.88 99.6 1586 8.5% A:G
11 rs17653687 133495899 0.19 98.5 1555 16.2% A:G

Abbreviations: MAF, minor allele frequency; SNP, single-nucleotide polymorphism.

Designations for the two single nucleotide polymorphisms that showed type I diabetes association are shown in bold.

HHS Vulnerability Disclosure